3 results match your criteria: "2 Regional Cancer Centre[Affiliation]"
J Med Screen
June 2019
2 Regional Cancer Centre, Stockholm-Gotland, Sweden.
Objective: Using quantitative Faecal Immunochemical Test (FIT) in colorectal cancer screening enables adjustment of the cut-off for a positive test. As men have higher stool blood levels and higher prevalence of colorectal neoplasia, different cut-off levels can be chosen for men and women. We evaluated participation and positivity rates switching from guaiac-based faecal occult blood test (gFOBT) (Hemoccult®) to FIT (OC-Sensor), using gender-specific cut-offs.
View Article and Find Full Text PDFJ Med Screen
September 2018
4 Department of Oncology-Pathology, Karolinska Institutet, Stockholm and Regional Cancer Centre, Stockholm-Gotland, Sweden.
Objectives: To assess patterns and probabilities of participation in multiple rounds of colorectal cancer screening.
Methods: All individuals who were invited to participate in population-based colorectal cancer screening in the Stockholm-Gotland region in Sweden between 1 January 2008 and 30 September 2015 were included in the study. Guaiac-based faecal occult blood testing was used.
Scand J Urol
December 2016
b 2 Regional Cancer Centre Uppsala Örebro, Uppsala University Hospital, Uppsala, Sweden.
Objective: Cancer quality registers are attracting increasing attention as important, but still underutilized sources of clinical data. To optimize the use of registers in quality assurance and improvement, data have to be rapidly collected, collated and presented as actionable, at-a-glance information to the reporting departments. This article presents a dashboard performance report on select quality indicators to cancer care providers.
View Article and Find Full Text PDF